APA (7th ed.) Citation

B, W., S, P., B, S., E, D., A, P., TK, E., . . . C, G. (2009). Direct injection of protamine-protected mRNA: Results of a phase 1/2 vaccination trial in metastatic melanoma patients. Journal of immunotherapy (Hagerstown, Md. : 1997), 32(5), 498. https://doi.org/10.1097/CJI.0b013e3181a00068

Chicago Style (17th ed.) Citation

B, Weide, et al. "Direct Injection of Protamine-protected MRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients." Journal of Immunotherapy (Hagerstown, Md. : 1997) 32, no. 5 (2009): 498. https://doi.org/10.1097/CJI.0b013e3181a00068.

MLA (9th ed.) Citation

B, Weide, et al. "Direct Injection of Protamine-protected MRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients." Journal of Immunotherapy (Hagerstown, Md. : 1997), vol. 32, no. 5, 2009, p. 498, https://doi.org/10.1097/CJI.0b013e3181a00068.